Apagrel� Tab 10 mg
Prasugrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets.
Prasugrel is a P2Y12 platelet inhibitor indicated for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI as follows:
Patients with unstable angina or, non-ST-elevation myocardial infarction (NSTEMI)
Patients with ST-elevation myocardial infarction (STEMI).
Apagrel® 5mg tablet : Box containing 3x10 tablets in Alu-Alu blister
Apagrel® 10mg tablet : Box containing 5x6 tablets in Alu-Alu blister